Albertsons Companies (ACI) Q1 2027 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2027 earnings summary
28 Jul, 2026Executive summary
Identical sales declined 0.8% year-over-year, while digital sales grew 13% and pharmacy remained strong despite IRA headwinds.
Net sales and other revenue rose 0.2% year-over-year to $24.94 billion, driven by higher fuel sales.
Net income was $84.7 million ($0.17 per share), with adjusted net income at $210.3 million ($0.42 per share); adjusted EBITDA was $1,013.2 million.
Launched ACI Edge, consolidating 11 divisions into four regions and centralizing merchandising to accelerate execution and improve competitiveness.
Continued investments in digital, loyalty, AI, and customer value to drive long-term growth and competitiveness.
Financial highlights
Gross margin was 26.6%, down from 27.1% year-over-year, mainly due to higher delivery, handling, and fuel costs and digital sales mix shift.
Selling and administrative expenses rose to 25.6% of revenue, up from 25.4%, impacted by rent, occupancy, litigation, and transformation costs.
Interest expense increased to $167 million from $142 million due to higher borrowings and rates.
Digital sales grew 13%, reaching nearly 10.5% penetration; e-commerce was profitable in Q1.
Capital expenditures were $522.1 million, including 15 remodels, four new stores, and digital investments.
Outlook and guidance
Fiscal 2026 identical sales expected to decline 1.5% to 0.5%, or 0% to 1% excluding a 150 bps pharmacy IRA headwind.
Adjusted EBITDA guidance: $3.55–$3.625 billion; adjusted EPS: $1.75–$1.85 per share.
Capital expenditures projected at $1.9–$2 billion; $600 million in share repurchases planned.
Expect gradual, modest improvement in identical sales through the year, with more visible gains in Q3 and Q4.
Effective tax rate guidance unchanged at 24–25%.
Latest events from Albertsons Companies
- Q4 delivered 2.3% ID sales growth and $855M adjusted EBITDA; 2025 targets 1.5%-2.5% growth.ACI
Q4 20259 Jul 2026 - Identical sales and digital growth lifted revenue, but margins narrowed and EBITDA declined.ACI
Q1 20268 Jul 2026 - Proxy covers director elections, governance reforms, and robust ESG and compensation practices.ACI
Proxy filing22 Jun 2026 - Key votes include director elections, auditor ratification, and governance amendments.ACI
Proxy filing22 Jun 2026 - Proxy covers director elections, compensation, governance reforms, and ESG priorities.ACI
Proxy filing8 Jun 2026 - Q4 net loss from opioid settlement; digital sales up 16% and dividend raised 13%.ACI
Q4 202614 Apr 2026 - Q3 delivered solid sales and digital growth, but faces post-merger litigation and margin pressure.ACI
Q3 202510 Jan 2026 - Q3 2025 saw 2.4% identical sales growth, strong digital gains, and major capital actions.ACI
Q3 20267 Jan 2026 - Q2 2025 saw 2.0% revenue growth, higher net income, and a $750M share buyback announcement.ACI
Q2 20267 Jan 2026